BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

792 related articles for article (PubMed ID: 10438374)

  • 1. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.
    Kumagai T; Kamada M; Igarashi C; Yuri K; Furukawa H; Chiba S; Kojima H; Saito A; Okui T; Yano S
    J Infect Dis; 1999 Sep; 180(3):834-7. PubMed ID: 10438374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic understanding and control of varicella-zoster virus infection.
    Asano Y
    Vaccine; 2008 Nov; 26(50):6487-90. PubMed ID: 18694794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of varicella-zoster virus cell-mediated immune response after varicella booster vaccination.
    Berger R; Luescher D; Just M
    Postgrad Med J; 1985; 61 Suppl 4():143-5. PubMed ID: 3014472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
    Breuer J; Schmid DS; Gershon AA
    J Infect Dis; 2008 Mar; 197 Suppl 2():S147-51. PubMed ID: 18419389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and treatment of VZV infections in patients with HIV.
    Gershon AA
    Herpes; 2001 Jul; 8(2):32-6. PubMed ID: 11867015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of varicella zoster virus antibodies despite detectable cell mediated immunity after vaccination.
    Ludwig B; Kraus FB; Allwinn R; Keim S; Doerr HW; Buxbaum S
    Infection; 2006 Aug; 34(4):222-6. PubMed ID: 16896582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acyclovir prophylaxis of varicella after household exposure.
    Huang YC; Lin TY; Chiu CH
    Pediatr Infect Dis J; 1995 Feb; 14(2):152-4. PubMed ID: 7746701
    [No Abstract]   [Full Text] [Related]  

  • 8. Humoral and cell-mediated immune responses in children and adults after 1 and 2 doses of varicella vaccine.
    Watson B
    J Infect Dis; 2008 Mar; 197 Suppl 2():S143-6. PubMed ID: 18419388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment.
    Balfour HH
    Scand J Infect Dis Suppl; 1991; 80():69-74. PubMed ID: 1666447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acyclovir therapy in varicella/zoster diseases in immunocompromised children with cancer].
    Kuhn N; Landbeck G
    Monatsschr Kinderheilkd; 1984 Feb; 132(2):105-9. PubMed ID: 6328285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital varicella-zoster virus infection and the failure to establish virus-specific cell-mediated immunity.
    Grose C
    Mol Biol Med; 1989 Oct; 6(5):453-62. PubMed ID: 2560525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten year follow-up of healthy children who received one or two injections of varicella vaccine.
    Kuter B; Matthews H; Shinefield H; Black S; Dennehy P; Watson B; Reisinger K; Kim LL; Lupinacci L; Hartzel J; Chan I;
    Pediatr Infect Dis J; 2004 Feb; 23(2):132-7. PubMed ID: 14872179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4(+) T cells.
    Levin MJ; Gershon AA; Weinberg A; Song LY; Fentin T; Nowak B;
    J Infect Dis; 2006 Jul; 194(2):247-55. PubMed ID: 16779732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.
    Leung TF; Li CK; Hung EC; Chan PK; Mo CW; Wong RP; Chik KW
    Eur J Haematol; 2004 May; 72(5):353-7. PubMed ID: 15059071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varicella-like illness caused by live varicella vaccine in children with acute lymphocytic leukemia.
    Brunell PA; Geiser CF; Novelli V; Lipton S; Narkewicz S
    Pediatrics; 1987 Jun; 79(6):922-7. PubMed ID: 3035478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postexposure prophylaxis of varicella in family contact by oral acyclovir.
    Asano Y; Yoshikawa T; Suga S; Kobayashi I; Nakashima T; Yazaki T; Ozaki T; Yamada A; Imanishi J
    Pediatrics; 1993 Aug; 92(2):219-22. PubMed ID: 8393173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of immunity to varicella in children with leukemia immunized with live attenuated varicella vaccine.
    Gershon AA; Steinberg SP
    N Engl J Med; 1989 Apr; 320(14):892-7. PubMed ID: 2538749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chickenpox complications among immunocompetent hospitalized children in Italy. Acyclovir-Chickenpox Italian Study Group.
    Manfredi R; Chiodo F; Titone L; Vierucci A; Catania S; Ghirardini G; Assanta N; Caramia G; Marcucci F; Loizzo B; Muscolino F
    Pediatr Med Chir; 1997; 19(2):99-104. PubMed ID: 9269026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of immunity to live attenuated varicella vaccine in healthy adults.
    Ampofo K; Saiman L; LaRussa P; Steinberg S; Annunziato P; Gershon A
    Clin Infect Dis; 2002 Mar; 34(6):774-9. PubMed ID: 11830801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of protective immunity after postexposure prophylaxis of varicella with oral aciclovir in the family setting.
    Yoshikawa T; Suga S; Kozawa T; Kawaguchi S; Asano Y
    Arch Dis Child; 1998 Jan; 78(1):61-3. PubMed ID: 9534679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.